Azitra, Inc. 8-K Filing Summary
Business Context and Reporting Period
This Form 8-K reports on the results of Azitra, Inc.'s 2025 Annual Meeting of Stockholders held on June 23, 2025. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in Branford, Connecticut. The filing details the voting outcomes for three proposals and the adjournment of the meeting regarding a fourth proposal.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Voting Results
- Proposal 1 (Election of Directors): Approved. Stockholders elected Francisco D. Salva, Travis Whitfill, Barbara Ryan, and John Schroer to the Board of Directors. Significant broker non-votes (7,225,742 shares) were recorded for all nominees.
- Proposal 3 (Ratification of Auditors): Approved. Grassi & Co., CPAs, P.C. was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Proposal 4 (Issuance of Shares): Approved. Stockholders authorized the issuance of more than 19.99% of outstanding common stock (including underlying warrants) pursuant to a purchase agreement with Alumni Capital LP to comply with NYSE American Rule 713(a).
- Proposal 2 (Increase in Authorized Shares): Not voted upon. The proposal to increase authorized common stock from 100,000,000 to 200,000,000 shares was not voted on due to a need for updated disclosure regarding the voting standard. The polls for this proposal remain open.
Outlook, Management Commentary, and Risks
The Annual Meeting was adjourned to allow additional time for stockholders to vote on Proposal No. 2. A Reconvened Annual Meeting is scheduled for July 3, 2025, at 11:00 a.m. Eastern Time, to be held virtually. Valid proxies submitted prior to the June 23 meeting remain valid for the reconvened meeting. The record date remains May 28, 2025. Management advises stockholders to read the definitive proxy statement and its supplements for important information.
Investor Verification Checklist
- Verify the outcome of Proposal No. 2 (increase in authorized shares) at the Reconvened Annual Meeting on July 3, 2025.
- Review the definitive proxy statement and the June 18, 2025 supplement for details on the voting standard for Proposal No. 2.
- Confirm the terms of the purchase agreement with Alumni Capital LP referenced in the approved Proposal No. 4.
- Check the Company's Form 10-K for the fiscal year ended December 31, 2024, for detailed financial performance and risk factors not included in this 8-K.